AVENUE SURGERY
14 THE AVENUE, WARMINSTER
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 37 | 43 | 86.0% | |
| HF 4 | 2011 | 35 | 41 | 85.4% | |
| HF 4 | 2012 | 33 | 33 | 100.0% | |
| HF 4 | 2013 | 34 | 34 | 100.0% | |
| HF004 | 2014 | 19 | 19 | 100.0% | |
| HF004 | 2015 | 16 | 16 | 100.0% | |
| HF004 | 2016 | 64 | 70 | 91.4% | |
| HF004 | 2017 | 65 | 72 | 90.3% | |
| HF004 | 2018 | 71 | 84 | 84.5% | |
| HF004 | 2019 | 79 | 90 | 87.8% | |
| HF004 | 2020 | 92 | 101 | 91.1% | |
| HF006 | 2021 | 104 | 110 | 94.5% | |
| HF006 | 2022 | 140 | 143 | 97.9% | |
| HF006 | 2023 | 140 | 141 | 99.3% |
